Improving the Antimicrobial Activity of Old Antibacterial Drug Mafenide: Schiff Bases and Their Bioactivity Targeting Resistant Pathogens

References

• Hamad A , KhanMA, RahmanKMet al. Development of sulfonamide-based Schiff bases targeting urease inhibition: synthesis, characterization, inhibitory activity assessment, molecular docking and ADME studies. Bioorg. Chem.102, 104057 (2020).
   PubMed Web of Science ®Google Scholar
• Werth BJ . Sulfonamides. https://www.msdmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/sulfonamides
   Google Scholar
• Moore ML , MillerCS, MillerE. Substituted sulfanilamides: III. N4-acyl-N1-hydroxy derivatives. J. Am. Chem. Soc.62(8), 2097–2099 (1940).
   Google Scholar
• Cancio LC . Topical antimicrobial agents for burn wound care: history and current status. Surg. Infect.22(1), 3–11 (2021).
   PubMed Web of Science ®Google Scholar
• Mendelson JA , LindseyD. Sulfamylon (mafenide) and penicillin as expedient treatment of experimental massive open wounds with C. perfringens infection. J. Trauma.2, 239–261 (1962).
   PubMedGoogle Scholar
• Hashmi DL , HaithL. The current state of topical burn treatments: a review. Curr. Trauma Rep.5, 160–168 (2019).
   Web of Science ®Google Scholar
• Glasser JS , GuymonCH, MendeK, WolfSE, HospenthalDR, MurrayCK. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients. Burns36, 1172–1184 (2010).
   PubMed Web of Science ®Google Scholar
• Afshari A , NguyenL, KahnSAet al. The effective duration of antimicrobial activity of mafenide acetate after reconstitution. J. Burn Care Res.39, 736–738 (2018).
   PubMed Web of Science ®Google Scholar
• Han CY , YangY, YuAQet al. Investigation on the mechanism of mafenide in inhibiting pyroptosis and the release of inflammatory factors. Eur. J. Pharm. Sci.147, 105303 (2020).
   PubMed Web of Science ®Google Scholar
• Barsoumian A , SanchezCJ, MendeKet al. In vitro toxicity and activity of Dakin's solution, Mafenide acetate, and amphotericin B on filamentous fungi and human cells. J. Orthop. Trauma27, 428–436 (2013).
   PubMed Web of Science ®Google Scholar
• Eagon RG , McManusAT. The effect of mafenide on dihydropteroate synthase. J. Antimicrob. Chemother.25, 25–29 (1990).
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. SULFAMYLON (Mafenide Acetate, USP) ® FOR 5% TOPICAL SOLUTION. https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/19832lbl.pdf.
   Google Scholar
• Zhang XJ , HeggersJP, ChinkesDL, WolfSE, HawkinsHK, WolfeRR. Topical sulfamylon cream inhibits DNA and protein synthesis in the skin donor site wound. Surgery139(5), 633–639 (2006).
   PubMed Web of Science ®Google Scholar
• Punjataewakupt A , NapavichayanunS, AramwitP. The downside of antimicrobial agents for wound healing. Eur. J. Clin. Microbiol. Infect. Dis.38, 39–54 (2019).
   PubMed Web of Science ®Google Scholar
• Capasso C , SupuranCT. Inhibition of bacterial carbonic anhydrases as a novel approach to escape drug resistance. Curr. Top. Med. Chem.17(11), 1237–1248 (2017).
   PubMed Web of Science ®Google Scholar
• Selvaraj S , KaruppaiahA, KarthikS, SankarV. Synthesis and toxicity assessment of copper-based nano composite cream: an approach to enhance the antibacterial effect of mafenide acetate. Inorg. Nano-Met. Chem.51(1), 27–37 (2021).
   Web of Science ®Google Scholar
• Harriott MM , BhindiN, KassisSet al. Comparative antimicrobial activity of commercial wound care solutions on bacterial and fungal biofilms. Anna Plast. Surg.83(4), 404–410 (2019).
   PubMed Web of Science ®Google Scholar
• Siuda JF , CihonskiCD. New compounds – carbamate derivatives of mafenide (homosulfanilamide). J. Pharm. Sci.61(11), 1856–1857 (1972).
   PubMed Web of Science ®Google Scholar
• Mermer A , DemirbasN, UsluH, DemirbasA, CeylanS, SirinX. Synthesis of novel Schiff bases using green chemistry techniques; antimicrobial, antioxidant, antiurease activity screening and molecular docking studies. J. Mol. Struct.1181, 151161 (2019).
   Web of Science ®Google Scholar
• Ceramella J , IacopettaD, CatalanoA, CirilloF, LappanoR, SinicropiMS. A review on the antimicrobial activity of Schiff bases: data collection and recent studies. Antibiotics11(2), 191 (2022).
   Google Scholar
• Cebeci YU , BayrakH, ŞirinY. Synthesis of novel Schiff bases and azol-β-lactam derivatives starting from morpholine and thiomorpholine and investigation of their antitubercular, antiurease activity, acethylcolinesterase inhibition effect and antioxidant capacity. Bioorg. Chem.88, 102928 (2019).
   PubMed Web of Science ®Google Scholar
• Kurt BZ , SonmezF, OzturkD, AkdemirA, AngeliA, SupuranCT. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. Eur. J. Med. Chem.183, 111702 (2019).
   PubMed Web of Science ®Google Scholar
• Krátký M , KonečnáK, JanoušekJet al. 4-Aminobenzoic acid derivatives: converting folate precursor to antimicrobial and cytotoxic agents. Biomolecules10, 1–21 (2020).
   Web of Science ®Google Scholar
• Krátký M , DzurkováM, JanoušekJet al. Sulfadiazine salicylaldehyde-based schiff bases: synthesis, antimicrobial activity and cytotoxicity. Molecules22, 1573 (2017).
   PubMed Web of Science ®Google Scholar
• Krátký M , VinšováJ, VolkováM, BuchtaV, TrejtnarF, StolaříkováJ. Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold. Eur. J. Med. Chem.50, 433–440 (2012).
   PubMed Web of Science ®Google Scholar
• Winthrop Chem. Co . KlarerJ. Benzenesulphonamide compounds. US2288531, 1940, A (1942).
   Google Scholar
• Tsukamoto T , YuhiK. Studies on halogenosalicylaldehyde. I: halogenosalicylaldehyde as reagent for primary amines. Yakugaku Zasshi78(7), 706–709 (1958).
   Google Scholar
• Matuschek E , BrownDF, KahlmeterG. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin. Microbiol. Infect.20(4), O255–O266 (2014).
   PubMed Web of Science ®Google Scholar
• European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST DISCUSSION DOCUMENT E.Dis 5.1. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect.9, 1–7 (2003).
   PubMed Web of Science ®Google Scholar
• European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST DEFINITIVE DOCUMENT EDEF 7.3.1. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Files/EUCAST_E_Def_7_3_1_Yeast_testing__definitive.pdf
   Google Scholar
• European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST DEFINITIVE DOCUMENT E.DEF 9.3.1. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Files/EUCAST_E_Def_9_3_1_Mould_testing__definitive.pdf
   Google Scholar
• Krátký M , KonečnáK, JanoušekJet al. Sulfonamide-salicylaldehyde imines active against methicillin- and trimethoprim/sulfonamide-resistant Staphylococci. Future Med. Chem.13, 1945–1962 (2021).
   PubMed Web of Science ®Google Scholar
• de Araújo Neto LN , doCarmo Alves de Lima M, de OliveiraJFet al. Synthesis, cytotoxicity and antifungal activity of 5-nitro-thiophene-thiosemicarbazones derivatives. Chem. Biol. Interact.272, 172–181 (2017).
   PubMed Web of Science ®Google Scholar
• Krátký M , VinšováJ. Sulphur-containing heterocycles as antimycobacterial agents: recent advances in thiophene and thiadiazole derivatives. Curr. Top. Med. Chem.16(26), 2921–2952 (2016).
   PubMed Web of Science ®Google Scholar
• Yadav V , TalwarP. Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: an underestimated truth. Biomed. Pharmacother.111, 934–946 (2019).
   PubMed Web of Science ®Google Scholar
• Al-Janabi AAHS . Repurposing of tamoxifen against the oral bacteria. Turk. J. Pharm. Sci.18, 68–74 (2021).
   PubMed Web of Science ®Google Scholar
• Dolan K , MontgomeryS, BuchheitB, DidoneL, WellingtonM, KrysanDJ. Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization. Antimicrob. Agents Chemother.53(8), 3337–3346 (2009).
   PubMed Web of Science ®Google Scholar
• Szczupak L , KowalczykA, TrzybińskiDet al. Organometallic ciprofloxacin conjugates with dual action: synthesis, characterization, and antimicrobial and cytotoxicity studies. Dalton Trans.49, 1403–1415 (2020).
   PubMed Web of Science ®Google Scholar
• Abdmouleh F , ElArbi M, BenSaad Het al. Antimicrobial, antitumor and side effects assessment of a newly synthesized tamoxifen analog. Curr. Top. Med. Chem.20(25), 2281–2288 (2020).
   PubMed Web of Science ®Google Scholar
• Felício MR , SilvaON, GonçalvesS, SantosNC, FrancoOL. Peptides with dual antimicrobial and anticancer activities. Front. Chem.5, 5 (2017).
   PubMed Web of Science ®Google Scholar